K U 725 (Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg)
Pill imprint K U 725 has been identified as Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg.
Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 25 mg / 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for K U 725 (Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg)
- 25 mg / 15 mg
- 14.00 mm
- Figure eight-shape
- Prescription only
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Cobalt Laboratories Inc
- National Drug Code (NDC):
- Inactive Ingredients:
polyethylene glycol 6000
ferric oxide red
More about hydrochlorothiazide/moexipril
- Hydrochlorothiazide and moexipril
- Moexipril and hydrochlorothiazide (Advanced Reading)
- Other brands: Uniretic